Investors
Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Key information
2018 Full year and fourth quarter results announcement
We will announce our full year and fourth quarter 2018 results at 12:00 GMT, 07:00 EST on Wednesday 06 February.
Following the announcement there will be a webcast, hosted by Emma Walmsley, CEO; Simon Dingemans, CFO; and other members of the CET at 14:00 GMT, 09:00 EST.
Latest information
Latest press releases
- GSK announces succession plan to appoint new Chairman
- Two positive phase III studies of tafenoquine for the radical cure of Plasmodium vivax malaria published in The New England Journal of Medicine
- GlaxoSmithKline plc and Pfizer Inc to form new world-leading Consumer Healthcare Joint Venture
GSK and Pfizer to form new world-leading Consumer Healthcare Joint Venture
On 19 December 2018 we announced our agreement with Pfizer to combine our consumer health businesses into a new world-leading Joint Venture. Watch Emma Walmsley discuss the proposed transaction and how we’re accelerating our strategy.